Does One-on-One Rehab Work?

What the research supports, and what it does not

The honest answer to "does one-on-one rehab work" has two halves. The treatments delivered inside a one-client program include well-studied treatments for addiction and mental health conditions. This guide does not cite a controlled head-to-head comparison of a full one-client program with a group program. So the evidence says: if a one-on-one program delivers the treatments below at adequate dose and duration, it is delivering what works. It does not say that the format adds anything on its own. What the format changes is participation: more clinical time per person, less pressure to disclose in front of strangers, and a schedule built around the person's actual life, which matters for people who could not or would not use a group program.

Swipe sideways to see all columns.

How to use this: ask any program, one-on-one or otherwise, which treatments it delivers, at what dose, for how long, and with what continuing care. Compare medication for alcohol or opioid use disorder, cognitive behavioral therapy, contingency management, trauma-focused therapy, treatment duration, continuing care, and family involvement where they fit the person's needs. Evidence for those treatments does not establish that one-client delivery is more effective than group delivery. Residence quality and amenities do not replace clinical treatment.

What does the evidence say about one-on-one rehab?

A one-on-one program can deliver treatments supported by research. That does not establish that treating one client at a time produces better outcomes than shared treatment; compare the methods, amount of care, and continuing support the program actually provides. The opening section, "What the research supports, and what it does not," lays that out with a table. Addiction treatment includes several different ingredients. A program can combine individual counseling, medication, family work, help with routines, and continuing support. NIDA's addiction treatment overview describes effective medications and behavioral treatments for substance use disorders. That supports using appropriate treatment methods; it does not supply a success rate for every program that uses them.

A study of individual counseling answers a different question from a comparison of entire residential programs. Participants, treatment duration, medication access, and follow-up can differ. Read the result in the context of what was actually studied. The number of clients in a residence is only one feature of the experience.

Start with what one-on-one rehab means if you are comparing an individual appointment with a program organized around one person. They are different units of care.

NIMH describes psychotherapy as a set of methods for addressing troubling thoughts, emotions, and behaviors, with goals and progress discussed during care. That is a useful level at which to evaluate an individual plan. The relevant questions concern the method, the target problem, the clinician's preparation, and what the person and clinician will do when improvement is insufficient.

Which claims can treatment research support?

Treatment research describes the methods used, the people studied, the comparison group, and the outcomes measured. A study of cognitive behavioral therapy, for example, answers a different question from a study comparing whole residential programs. Useful results state whether they measured substance use, symptoms, retention, functioning, or another outcome, and when follow-up occurred. The reader also needs to know how many participants supplied follow-up information. These details explain what a result means and how closely the study population resembles the person considering care.

A completion rate measures finishing a program; reduced substance use, improved functioning, and sustained follow-up measure other outcomes. Those results answer different questions and cannot be treated as interchangeable evidence.

Swipe sideways to see all columns.

What does a rehab success rate actually measure?

A meaningful success claim identifies the outcome, when it was measured, who was included, and how missing follow-up was handled. Those details identify the people counted and the outcome the percentage measures.

Follow-up matters. Results recorded on the last day of a residential stay describe life inside that setting. Results gathered after returning home answer a different question. A report should make clear how missing responses were handled and whether the same questions were asked consistently.

A provider does not need to publish a research study to explain how it measures progress. It needs a clear account of the changes followed, the timing of review, and how findings affect care. An absent marketing percentage is not itself evidence of poor treatment.

How can individual treatment make participation easier?

The practical reasons for individual appointments include privacy, a tailored pace, and focused time on a specific concern. A consistent team reduces repeated introductions, while an adaptable schedule accommodates relevant outside appointments. These are features to evaluate, not evidence that the format has superior outcomes.

Prior care provides useful information about participation. Individual sessions address some barriers, while transport, an unsuitable treatment method, untreated symptoms, and the transition home require different changes.

The benefits and tradeoffs guide helps turn preferences into concrete questions. Individual therapy time helps compare the actual appointments within different programs.

How should progress be reviewed during treatment?

Before beginning, identify a few meaningful goals with the treating team. These might concern substance use, sleep, daily activities, medication follow-through, relationships, or returning to work. Agree on how changes will be discussed and when the plan will be reconsidered.

A useful review includes both the person's experience and relevant clinical information. If attendance is consistent but symptoms or functioning are not improving, the next step may be to adjust the method, intensity, medication plan, or support between sessions. More of the same is not the only option.

A return to substance use warrants a prompt review of safety and treatment needs. NIDA's Treatment and Recovery overview explains that relapse can signal a need to resume or change care. It is not proof that recovery is impossible. The prior-treatment review organizes that conversation.

Why does the plan after rehab matter?

Because most of recovery happens after the program ends. NIDA's research summary is blunt about duration: people generally need at least three months in treatment, across levels of care, to significantly reduce or stop use, and longer engagement is associated with better outcomes. A 30-day one-client stay is an intensive first phase of treatment.

What the plan after rehab should contain: the first therapy and prescribing appointments booked before discharge, medication supply that does not lapse in the handoff, a living arrangement that has been assessed rather than assumed, named people who know the plan, and a written response if use returns. For someone going back to frequent travel, the plan has to work in hotels; for someone returning to a household where substances are available, it has to change the household or the residence.

Ask the program how it handles the first 90 days, who is responsible for each piece, and whether the same clinicians stay involved. A program that treats discharge as the finish line is offering 30 days of good care and 335 days of nothing.

What evidence would show that the format itself works?

A claim about the one-client format requires evidence that isolates that feature from the treatment delivered inside it. A program offering a particular therapy, medication, and high appointment frequency has several active components. An improvement after attendance does not identify which component caused the change.

A useful comparison would describe the people entering each format, their starting severity, the methods delivered, time in treatment, and follow-up after discharge. Differences in budget, housing, existing support, and readiness to participate also affect interpretation. Without that information, a testimonial or before-and-after account is an individual experience rather than comparative evidence for an entire category.

The distinction does not make individual preferences unimportant. A person needs to attend and participate in treatment for the clinical work to take place. An arrangement that solves a real access or engagement problem is worth considering on that basis. It still needs the correct treatment method, appropriate medical services, and a sustainable next phase.

Continuing care also changes what a program result means. Finishing an initial stay is not the same outcome as maintaining progress after returning to ordinary responsibilities. Follow-up information needs to identify how long people were observed and whose results were missing. A program that explains uncertainty and the limits of its information is making a more assessable claim than one that offers a single unexplained success rate.

Questions about one-on-one rehab outcomes

Sources and further reading

• NIDA: Treatment and Recovery
• NIDA: Addiction Treatment
• NIMH: Psychotherapies
• NIDA: Principles of Drug Addiction Treatment
• SAMHSA TIP 63: Medications for Opioid Use Disorder
• Cochrane: Buprenorphine maintenance versus placebo or methadone
• Cochrane: Methadone maintenance versus no opioid replacement therapy
• Cochrane: Acamprosate for alcohol dependence
• NIH: Methadone and buprenorphine reduce risk of death after opioid overdose
• APA: Depression Treatments for Adults
• VA: Treatment of Co-Occurring PTSD and Substance Use Disorder
• ASAM and AAAP: Clinical Practice Guideline on Stimulant Use Disorder
• SAMHSA: Evidence-Based Contingency Management Services
• NIAAA: Evidence-Based Alcohol Treatment Options
• Santo et al. (2021): Opioid agonist treatment and mortality

Sources checked September 7, 2026